| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/23/2004 | US20040259844 Method and composition for preventing, reducing and reversing ocular ischemic neuronal damage |
| 12/23/2004 | US20040259843 Antidiabetic agents; hyperglycemic agents; obesity; atherosclerosis; immunomodulatory agents |
| 12/23/2004 | US20040259842 Anticoagulants ; antiischemic agents; autoimmune disease; antihistamines; antiallergens; antihistamines; brain disorders; kidney disease; pancreatitis; Alzheimer's disease |
| 12/23/2004 | US20040259841 Low molecular weight; nutritional supplement; softening of human skin;orally administering |
| 12/23/2004 | US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis |
| 12/23/2004 | US20040259839 Foods, printing dyes, oil well drilling fluids, ceramic glaze, drugs |
| 12/23/2004 | US20040259838 Staphylococcus aureus exopolysaccharide and process |
| 12/23/2004 | US20040259835 Stabilized brivudine topical formulations |
| 12/23/2004 | US20040259834 Therapeutic composition containing at least diflomotecan and capecitabine |
| 12/23/2004 | US20040259833 DNA methyl transferase inhibitors |
| 12/23/2004 | US20040259832 Synergistic mixture of thymidine kinase inhibitor and viricides |
| 12/23/2004 | US20040259829 Carboxylesterase; antitumor agents; drug screening; bioassay |
| 12/23/2004 | US20040259826 Mitotic kinesin inhibitors |
| 12/23/2004 | US20040259822 Antibody which recognizes epitope containing nucleic acid coupled to active protein; hybridomas |
| 12/23/2004 | US20040259821 In nonaqueous solvent; therapy for blood disorders; anticancer agents |
| 12/23/2004 | US20040259820 Kit for delivering decitabine in vivo |
| 12/23/2004 | US20040259819 Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof |
| 12/23/2004 | US20040259817 Methods and formulations for the treatment of female sexual dysfunction |
| 12/23/2004 | US20040259816 Compositions comprising plant-derived polyphenolic compounds and inhibitors of reactive oxygen species and methods of using thereof |
| 12/23/2004 | US20040259815 Synergistic mixture containing tyrosine kinase inhibitor with carotenoils, flavonoids, apigenin |
| 12/23/2004 | US20040259813 Using a ketone chalcone compound |
| 12/23/2004 | US20040259810 Porphyrin derivatives for photodynamic therapy |
| 12/23/2004 | US20040259809 Pharmaceutical compositions including an antihistamine and a stimulant and method of use thereof |
| 12/23/2004 | US20040259808 Captopril derivatives |
| 12/23/2004 | US20040259799 Use of heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin a for the treatment of beta-thalassaemia |
| 12/23/2004 | US20040259793 Methods and compositions for modulating proteins modified in preconditioning against ischemia/hypoxia |
| 12/23/2004 | US20040259792 Inhibitors of phosphodiesterases in infertility |
| 12/23/2004 | US20040259788 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 12/23/2004 | US20040259784 Compositions and methods for treatment of muscle pain and muscle wasting |
| 12/23/2004 | US20040259783 Pharmaceutical compositions of marine sponge microciona prolifera |
| 12/23/2004 | US20040259772 Use of a histone deacetylase inhibitor to increase the entry of an adenoviral agent into a cell |
| 12/23/2004 | US20040259767 Antiproliferative agents; therapy for human progessive leukoencephalophy ; suppression of dna viruses; anticancer agents |
| 12/23/2004 | US20040259766 Use of glutamate, glutamate derivatives or metabolites, glutamate analogues or mixtures thereof for the manufacture of a composition for the treatment of osteoporosis |
| 12/23/2004 | US20040259765 Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis |
| 12/23/2004 | US20040259764 Reticulocyte depletion signatures |
| 12/23/2004 | US20040259248 RNA interference mediating small RNA molecules |
| 12/23/2004 | US20040259247 short interfering RNAs for use treating diseases, in protein separation or purification, in drug screening; cell with target gene-specific knockout phenotype; double stranded RNA; RNA fragments are the sequence-specific mediators of RNAi (RNA interference) |
| 12/23/2004 | US20040259245 Complete nutrient medium for use as a cosmetic and cosmetic use thereof |
| 12/23/2004 | US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment |
| 12/23/2004 | US20040259185 Macrolide analogs and methods for identifying same |
| 12/23/2004 | US20040259179 evaluating the likelihood of whether an individual will benefit from treatment with an agent for reducing risk of a future cardiovascular event, such as atherosclerosis, myocardial infarction and stroke by measuring the level of sterols |
| 12/23/2004 | US20040259171 P2Y4 antibody and methods of use |
| 12/23/2004 | US20040259136 diagnosis of arthritis based on elevated test amount of a zeta PKC gene product; drug screening, antisense agents and short interfering RNA (siRNA) |
| 12/23/2004 | US20040259110 Gene PRV-1 and its use |
| 12/23/2004 | US20040259097 Method for the in vitro synthesis of short double stranded rnas |
| 12/23/2004 | US20040259084 Diagnostic and therapeutic methods based on the l1 adhesion molecule for ovarian and endometrial tumors |
| 12/23/2004 | US20040258826 Matrix-forming composition containing pectin |
| 12/23/2004 | US20040258782 Isolation of lutein from alfalfa |
| 12/23/2004 | US20040258781 Cyclooxygenase-2 inhibitory withanolide compositions and method |
| 12/23/2004 | US20040258779 A cytoprotective soy isoflavone and peptidoglycan of Lactobacillus Plantarum, N-acetyl-glucosamine-N-acetyl-muramyl-L-alanine-D-isoglutamine-meso-diaminopimelyl-D-alanine; antiapoptotic agents; humans and domesticated animals |
| 12/23/2004 | US20040258774 Manual clitoral sensitizing mixture having a cooling agent chosen from oils of peppermint, cornmint, eucalyptus, camphor, citronella and cinnamon |
| 12/23/2004 | US20040258773 Composition and methods for treating subjects with hyperglycemia |
| 12/23/2004 | US20040258771 Reduced toxicity cisplatin formulations and methods for using the same |
| 12/23/2004 | US20040258770 1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine, a platinum compound, an antineoplastic antimetabolic agent and folinic acid; colorectal cancer |
| 12/23/2004 | US20040258769 Use of ocular vitamins in conjunction with other treatment methods for AMD |
| 12/23/2004 | US20040258765 Topical antiulcer and wound healing agent comprising bee pollen, bee propolis, honey, and/or royal jelly; and caffeine; health beverages; skin disorders, herpes viral infections; spray, shampoo, soap, lipstick, or adhesive bandages |
| 12/23/2004 | US20040258758 Stabilizer adsorped on particle surface; adhere to gut increasing time for absorption, and effectiveness; low dosage; antiepileptic, anxiolytic and antidepressant agents; post traumatic stress syndrome bipolar and psychological disorders; schizophrenia |
| 12/23/2004 | US20040258757 Liquid dosage compositions of stable nanoparticulate active agents |
| 12/23/2004 | US20040258756 Novel process |
| 12/23/2004 | US20040258755 Dissolved cis[((1R,2R)-1,2-cyclohexanediamine-N,N')bis(alkanoyloxy)]platinum(II) in 2-methyl-2-propanol; stabile, easily handled injection; fine, homogenous suspension; controlled particle size distribution |
| 12/23/2004 | US20040258754 Compositions for oral administration of camptothecin and its analogs |
| 12/23/2004 | US20040258751 Mixing ribavirin with excipient; pelletization; coating with material that reduces dissolution rate in water; sustained release, free-flowing |
| 12/23/2004 | US20040258750 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 12/23/2004 | US20040258749 Side effect reduction; retarder coating; embedded in matrix; sustained release |
| 12/23/2004 | US20040258748 Compressing mixture of drug and effervescent acid source and base to produce a tablet; moisture activation; disintegration; drugs such as rofecoxib, simvastatin, olanzapine; and sodium bicarbonate |
| 12/23/2004 | US20040258747 NGR(asparagine-glycine-arginine) molecule linked to encapsulating vehicle capable of delivering folds of antitumor agents comprising doxorubicin, vincristine, mitoxantrone, calicheamicin, Iressa, or Gleevec; anticarcinogenic agents; amino-polyethylene glycol phosphatidylethanolamine derivative liposomes |
| 12/23/2004 | US20040258745 Pharmaceutical composition containing artificial oxygen carrier |
| 12/23/2004 | US20040258741 Percutaneous absorption preparations |
| 12/23/2004 | US20040258740 Transdermal delivery composition |
| 12/23/2004 | US20040258734 Cranberry seed oil extract and compositions containing components thereof |
| 12/23/2004 | US20040258733 Dentifrice, chewing gum, confection, lozenge, mouthwash, mouth spray or edible film; bactericides; food acid, anticaries agent, antitartar agent, softener, plasticizer, essential oil, emulsifiers |
| 12/23/2004 | US20040258731 Preparation approriate for cartilage tissue formation |
| 12/23/2004 | US20040258730 Sustained relase film comprises (11Apha ,13E,15 alpha )-9-oxo-11,15-dihydroxy-16-(3-methoxymethylphenyl)-17,18,19,20-tetranor-5-thiaprost-13-enoic acid methyl ester to treat bone mass disorders; osteoporosis, metastatic bone, hypercalcemia, and Paget's disease |
| 12/23/2004 | US20040258728 Delivery of drug coated stent; administered systemically; antiinflammatory and antiproliferative agents |
| 12/23/2004 | US20040258721 Water in oil emulsion has moisturizer of glycerol, chitosan, Fucogel, propylene glycol, polyoxyethylene glycol, dipropylene glycol, butylene glycol, mannitol, lactic acid, glycine,, sodium 2-pyrrolidone-5-carboxylate, hyaluronic acid, urea, and/or salts; storage stability; acne, wrinkle resistance |
| 12/23/2004 | US20040258720 Cosmetics; skin disorders, antiinflammatory agents |
| 12/23/2004 | US20040258719 External preparation for treating dermatosis and pruritus due to hemodialysis |
| 12/23/2004 | US20040258718 Synergistic mixed poloxamer systmes for the solubilisation of drugs |
| 12/23/2004 | US20040258717 Cosmetic and dermatological preparations containing creatine for treating and actively preventing dry skin and other negative alterations of the physiological homeostasis of the healthy-skin |
| 12/23/2004 | US20040258716 Spill-resistant, semi-solid, aqueous pharmaceutical suspension for oral administration comprising a water-insoluble medicine in a stabilizing vehicle of glycerin, sorbitol, propylene glycol and thickener, e.g. Carbopol"; palatable; homogeneous; shelf life of <36 months; crystal growth inhibitors |
| 12/23/2004 | US20040258711 Adding a synthetic folate to a growth environment of substrate and water for cultivation of mushroom-producing fungi having an enhanced content of reduced, methylated, biologically active folates; nutritional supplements readily absorbed; treating cardiovascular disease in humans having hypothyroidism |
| 12/23/2004 | US20040258702 Immunogen formulation comprising antigen, biocompatible polymer and liquid vehicle for stimulation of an immune response; the polymer interacts with the liquid vehicle to impart reverse thermal viscosity behavior to the composition, i.e. reverse thermal gelation; potentiation |
| 12/23/2004 | US20040258692 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 12/23/2004 | US20040258686 Mammalian receptor proteins; related reagents and methods |
| 12/23/2004 | US20040258682 Monoclonal antibody or fragment engineered in non-Fc constant heavy or light region; immunoconjugates for cancer diagnosis and therapy |
| 12/23/2004 | US20040258674 Food or beverage formulation for improving cardiovascular health |
| 12/23/2004 | US20040258662 Antineoplastic agents |
| 12/23/2004 | US20040258657 Antitumor agent containing cyclic polylactic acid |
| 12/23/2004 | US20040258647 Active ingredient-containing cosmetic cleansing emulsions |
| 12/23/2004 | US20040258626 Combination of medicament and lactose particles; accurate, uniform, consistent dispersion for multidose dry powder inhaler |
| 12/23/2004 | US20040258622 Nonozone depleting aerosol formulation employing hydrofluoroalkane propellants |
| 12/23/2004 | US20040258621 Method of treating snoring and other obstructive breathing disorders |
| 12/23/2004 | US20040256749 Process for production of essentially solvent-free small particles |
| 12/23/2004 | US20040256745 Oxygen inhalation apparatus and method |
| 12/23/2004 | US20040255959 Method and compounds to decrease the incidence of atrial fibrillation (AF) in patients with left ventricular dysfunction |
| 12/23/2004 | US20040255395 Process for increasing liquid extraction from fabrics |
| 12/23/2004 | DE3790581B4 Verfahren zur selektiven Vernichtung von hypoxischen Tumorzellen Process for the selective destruction of hypoxic tumor cells |
| 12/23/2004 | DE19801811B4 Pharmazeutische Zubereitung zur oralen Verabreichung Pharmaceutical preparation for oral administration |
| 12/23/2004 | DE10326186A1 Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Bicyclic heterocycles, pharmaceutical compositions containing them, their use and process for their preparation |
| 12/23/2004 | DE10326103A1 Synergistic mixture of analgesic and inhibitor of cyclo-oxygenase II, useful for treatment of pain, effective at low doses and with reduced side effects |